Literature DB >> 9705828

Cyclo-oxygenase-2 regulates inducible ICAM-1 and VCAM-1 expression in human vascular smooth muscle cells.

D Bishop-Bailey1, A Burke-Gaffney, P G Hellewell, J R Pepper, J A Mitchell.   

Abstract

Prostaglandins are well characterised inflammatory mediators, whose formation is regulated by constitutive (COX-1) or inducible (COX-2) isoforms of cyclo-oxygenase. We have previously demonstrated that IL-1 beta causes an induction of COX-2 in human vascular smooth muscle (1). This present study investigates the ability of different cytokines to induce ICAM-1 and VCAM-1 on human vascular smooth muscle, and tests whether co-induced COX-2 would regulate their expression. IL-1 beta induced ICAM-1, and COX activity, while it had no affect on VCAM-1. Conversely, IL-4 induced VCAM-1, while it had no effect on PGE2 release or ICAM-1 expression. Inhibition of IL-1 beta induced COX-2 and elevated ICAM-1 expression, an effect reversed by exogenous PGE2. Furthermore, IL-1 beta inhibited IL-4 induced VCAM-1 expression, which was also reversed by COX-2 inhibition. These results demonstrate that COX-2 limits adhesion molecule expression on human vascular smooth muscle cells and suggest that COX-2 can play a protective role in cardiovascular and inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705828     DOI: 10.1006/bbrc.1998.8966

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Synergistic effects of matrix nanotopography and stiffness on vascular smooth muscle cell function.

Authors:  Somali Chaterji; Peter Kim; Seung H Choe; Jonathan H Tsui; Christoffer H Lam; Derek S Ho; Aaron B Baker; Deok-Ho Kim
Journal:  Tissue Eng Part A       Date:  2014-04-02       Impact factor: 3.845

2.  Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence.

Authors:  M N Muscará; N Vergnolle; F Lovren; C R Triggle; S N Elliott; S Asfaha; J L Wallace
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

3.  Rebamipide reduces indomethacin-induced gastric injury in mice via down-regulation of ICAM-1 expression.

Authors:  Tetsuro Hiratsuka; Seiji Futagami; Tomotaka Shindo; Tatsuhiko Hamamoto; Nobue Ueki; Kenji Suzuki; Yoko Shinji; Masanori Kusunoki; Kei Shinoki; Ken Wada; Kazumasa Miyake; Katya Gudis; Taku Tsukui; Choitsu Sakamoto
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

Review 4.  COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to date.

Authors:  Michael Riedel; Martin Strassnig; Markus J Schwarz; Norbert Müller
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Selective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomach.

Authors:  N Maricic; K Ehrlich; B Gretzer; R Schuligoi; M Respondek; B M Peskar
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

6.  Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions.

Authors:  U Schönbeck; G K Sukhova; P Graber; S Coulter; P Libby
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

7.  Prostaglandin E₂-induced intercellular adhesion molecule-1 expression is mediated by cAMP/Epac signalling modules in bEnd.3 brain endothelial cells.

Authors:  Tae Yeop Park; Eun Joo Baik; Soo Hwan Lee
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

Review 8.  Effects of Modifications on the Immunosuppressive Properties of Cyclolinopeptide A and Its Analogs in Animal Experimental Models.

Authors:  Michał Zimecki; Krzysztof Kaczmarek
Journal:  Molecules       Date:  2021-04-27       Impact factor: 4.411

9.  Gene expression profiles and signaling mechanisms in α2B-adrenoceptor-evoked proliferation of vascular smooth muscle cells.

Authors:  Anna Huhtinen; Vesa Hongisto; Asta Laiho; Eliisa Löyttyniemi; Dirk Pijnenburg; Mika Scheinin
Journal:  BMC Syst Biol       Date:  2017-06-28

Review 10.  Identification of Active Compounds From Yi Nationality Herbal Formula Wosi Influencing COX-2 and VCAM-1 Signaling.

Authors:  Ji-Zhong Zhang; Xiao-Yi Chen; You-Jiao Wu; Li-Min Li; Li Huang; Qiao-Zhi Yin; Pei Luo; Yuan Liu
Journal:  Front Pharmacol       Date:  2020-11-09       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.